Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A syndromic X-linked intellectual disability characterized by moderate intellectual disability, seizures, dysmorphic facial features and in some older patients slowly progressive unsteady gait and progressive weakness that has material basis in variation in the chromosomal region Xq21.33-q23.
Features include sometimes findings: Shrinkage of the cerebellum (cerebellar atrophy) and Peripheral neuropathy. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Poor speech, Moderate intellectual disability, Seizure |
Biomarker and diagnostic research for syndromic X-linked intellectual disability Chudley-Schwartz type has been reported in the published literature.
No clinical trials have been registered for syndromic X-linked intellectual disability Chudley-Schwartz type.
171 publications have been identified in PubMed for syndromic X-linked intellectual disability Chudley-Schwartz type. Research spans Basic Science / Preclinical (55%), Case Report / Case Series (18%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 88 | 55% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Online Mendelian Inheritance in Man
2 |
Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis) |
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Head and neck | 1 | Mandibular prognathia |
Patient case studies |
29 |
18% |
Research summaries | 17 | 11% |
Disease patterns and progression | 12 | 8% |
Testing and diagnosis research | 7 | 4% |
New treatment approaches | 5 | 3% |
Clinical study results | 1 | 1% |
Rishabh RK (2026). [PMID: 42220602](https://pubmed.ncbi.nlm.nih.gov/42220602/). *JCEM Case Rep*. [Case Report / Case Series]
Tripathi M (2026). [PMID: 36256770](https://pubmed.ncbi.nlm.nih.gov/36256770/). *Unknown Journal*. [Basic Science / Preclinical]
Kornfeld-Sylla SS (2026). [PMID: 41663425](https://pubmed.ncbi.nlm.nih.gov/41663425/). *Nat Commun*. [Basic Science / Preclinical]
Brott JT (2026). [PMID: 42048321](https://pubmed.ncbi.nlm.nih.gov/42048321/). *PLoS One*. [Basic Science / Preclinical]
Campanale A (2026). [PMID: 41386393](https://pubmed.ncbi.nlm.nih.gov/41386393/). *Prog Neuropsychopharmacol Biol Psychiatry*. [Basic Science / Preclinical]
Farooqi NNU (2026). [PMID: 41982083](https://pubmed.ncbi.nlm.nih.gov/41982083/). *Dev Neurobiol*. [Basic Science / Preclinical]
Gonzalez D (2026). [PMID: 41272343](https://pubmed.ncbi.nlm.nih.gov/41272343/). *Mol Psychiatry*. [Basic Science / Preclinical]
Ahmed A (2026). [PMID: 41864249](https://pubmed.ncbi.nlm.nih.gov/41864249/). *Neuroimage*. [Basic Science / Preclinical]
Kessler C (2026). [PMID: 40961460](https://pubmed.ncbi.nlm.nih.gov/40961460/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Epidemiology / Natural History]
Martins AMA (2026). [PMID: 41714632](https://pubmed.ncbi.nlm.nih.gov/41714632/). *Sci Data*. [Basic Science / Preclinical]